Strumento inattivo

Azioni Accentia Biopharmaceuticals Inc

Azioni

Durata

Periodo

Stile

Accentia Biopharmaceuticals Inc : Biovest Names Lymphoma Key Opinion Leader from MD Anderson Cancer Center to Scientific Advisory Board	12/09/12
Accentia Biopharmaceuticals Inc : Biovest’s Eligibility to Seek EU Marketing Approval for its BiovaxID Cancer Vaccine as Orphan Drug Confirmed by EMA	13/07/12
Accentia Biopharmaceuticals Inc : Biovest Names Dr. Eduardo Sotomayor, Chair of Dept of Malignant Hematology at Moffitt Cancer Center, to its Scientific Advisory Board	30/05/12
Accentia Biopharmaceuticals Inc : Biovest Announces BiovaxID® ASCO Abstract Available On-line; NCI to Present Cancer Vaccine Data from Mantle Cell Lymphoma Study	19/05/12
Accentia Biopharmaceuticals Inc : Biovest Retains Ferghana Partners to Evaluate Strategic Transactions	16/05/12

Settore

	Variaz. 1 gen.	Capi.
IQVIA HOLDINGS INC.	+0,17%	42,86 Mrd
MODERNA, INC.	+10,92%	42,74 Mrd
LONZA GROUP AG	+44,30%	41,36 Mrd
CELLTRION, INC.	-6,20%	27,68 Mrd
ICON PUBLIC LIMITED COMPANY	+5,23%	25,15 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-24,79%	18,63 Mrd
MEDPACE HOLDINGS, INC.	+26,69%	12,37 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,13%	11,92 Mrd
UNITED THERAPEUTICS CORPORATION	+6,57%	11,21 Mrd